Literature DB >> 20363016

Correlation and association of plasma interleukin-6 and plasma platelet-derived microparticles, markers of activated platelets, in healthy individuals.

Tetsuya Ueba1, Shosaku Nomura, Norihito Inami, Tomofumi Nishikawa, Motohiro Kajiwara, Ryoichi Iwata, Kohsuke Yamashita.   

Abstract

INTRODUCTION: The aim of this study was to clarify the correlation and association of plasma IL-6 and PDMPs, both of which are associated with metabolic syndrome, in healthy individuals.
MATERIALS AND METHODS: We conducted a cross-sectional study of 464 healthy Japanese volunteers (210 men and 254 women, median age 39 and 35years, respectively) who had no signs, symptoms or history of cardiovascular- or cerebrovascular disease and took no medications. We assayed their IL-6 levels with a conventional ELISA kit and their PDMP levels by ELISA and monoclonal antibodies against CD42b and CD42a (glycoprotein Ib and IX).
RESULTS: By multivariate analysis, the plasma level of PDMP was correlated with diastolic blood pressure (p=0.015), platelet count (p<0.001), high sensitivity C-reactive protein, and the plasma level of IL-6 (p<0.001) in men (R(2)=0.454, p<0.001) and was correlated with platelet count (p<0.001) and the plasma level of IL-6 (p<0.001) in women (R(2)=0.159, p<0.001). Quartile range of plasma level of IL-6 was associated with plasma level of PDMP after adjustment for diastolic blood pressure, platelet count, and high sensitivity C-reactive protein in men (p<0.001) and associated with plasma level of PDMP after adjustment for platelet count in women (p<0.001).
CONCLUSIONS: These results suggest the plasma IL-6 is correlated and associated with the plasma PDMPs, markers of activated platelets in healthy individuals. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363016     DOI: 10.1016/j.thromres.2010.03.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Authors:  Lara Zafrani; Grigoris Gerotziafas; Colleen Byrnes; Xuzhen Hu; Joelle Perez; Charlène Lévi; Sandrine Placier; Emmanuel Letavernier; Asada Leelahavanichkul; Jean-philippe Haymann; Ismail Elalamy; Jeffrey L Miller; Robert A Star; Peter S T Yuen; Laurent Baud
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

Review 2.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

3.  The influence of body mass index, age and sex on inflammatory disease risk in semi-captive Chimpanzees.

Authors:  Vincent Obanda; George Paul Omondi; Patrick Ilukol Chiyo
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

4.  Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases.

Authors:  Jun-Xuan Lv; Qi Kong; Xin Ma
Journal:  Chronic Dis Transl Med       Date:  2017-11-26

Review 5.  Clinical requirements for extracellular vesicle assays.

Authors:  Lisa Ayers; Ryan Pink; David Raul Francisco Carter; Rienk Nieuwland
Journal:  J Extracell Vesicles       Date:  2019-03-27

Review 6.  Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis.

Authors:  Matthew J McConnell; Reiichiro Kondo; Nao Kawaguchi; Yasuko Iwakiri
Journal:  Hepatol Commun       Date:  2021-11-10

7.  Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial.

Authors:  Lisa Ayers; Anne-Christin Stoewhas; Berne Ferry; Tsogyal D Latshang; Christian M Lo Cascio; Ross Sadler; Katrin Stadelmann; Noemi Tesler; Reto Huber; Peter Achermann; Konrad E Bloch; Malcolm Kohler
Journal:  Eur J Appl Physiol       Date:  2014-02-11       Impact factor: 3.078

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.